8. Stockholders' Equity | 12 Months Ended |
Dec. 31, 2012 |
Stockholders' Equity (Deficit) | ' |
8. Stockholders' Equity | ' |
Common Stock |
|
As of December 31, 2012, 2011 and 2010 the Company had 1,187,956,895 and 903,701,378 and 903,701,378 shares of common stock issued and outstanding. |
|
In January 2010 the Company issued 1,000,000 shares of common stock for consulting services totaling $60,000. |
|
In February 2010 the Company issued 803,137 shares of common stock for legal services totaling $16,063. |
|
In February 2010 the Company issued 54,000,000 shares of common stock for accrued operating obligations totaling $1,350,000. |
|
In February 2010 the Company issued 13,020,000 shares of common stock for the settlement of notes payable totaling $331,700 inclusive of penalty interest of $14,000. |
|
In March 2010 the Company issued 16,980,000 shares of common stock for the settlement of notes payable totaling $424,500. |
|
In March 2010 the Company issued 250,000 shares of common stock for consulting services totaling $35,000. |
|
In March 2010 the Company issued 8,000,000 shares of common stock for the settlement of notes payable and accrued interest totaling $323,123. |
|
In March 2010 the Company issued 8,376,169 shares of common stock as part of a note payable arrangement resulting in the recognition of interest expense totaling $376,928. |
|
In March 2010 the Company issued 14,750,000 shares of common stock as part of a note payable arrangement resulting in the recognition of interest expense totaling $433,803. |
|
In April 2010 the Company issued 20,000,000 shares of common stock for the settlement of notes payable and accrued interest totaling $568,501 and recognized a loss on extinguishment of $331,182. |
|
In April 2010 the Company issued 100,000 shares of common stock for consulting services totaling $6,000. |
|
In May 2010 the Company issued 900,000 shares of common stock for the settlement of notes payable and accrued interest totaling $26,719 and recognized a loss on extinguishment of $43,424. |
|
In June 2010 the Company issued 17,983,333 shares of common stock for the settlement of notes payable totaling $362,000. |
|
In June 2010 the Company issued 250,000 shares of common stock for Board of Director compensation totaling $22,500. |
|
In July 2010 the Company canceled 14,250,000 shares of common stock previously issued as part of a note payable agreement. |
|
In September 2010 the Company issued 29,383,333 shares of common stock for the settlement of notes payable totaling $235,000 and recognized a loss on the settlement of $31,875. |
|
In September 2010 the Company issued 12,300,000 shares of common stock as part of a note payable arrangement and initially recognized deferred loan costs totaling $495,600. |
|
In September 2010 the Company issued 22,154,107 shares of common stock for accrued professional fees totaling $981,099. |
|
In October, 2010 the Company issued 5,000,000 shares of common stock for the settlement of previously accrued professional fees totaling $25,000 and the recognition of financing fees included in interest expense of $37,500. |
|
In November 2010 the Company issued 6,250,000 shares of common stock for the settlement of previously accrued professional fees totaling $25,000 and the recognition of financing fees included in interest expense of $35,000. |
|
In December 2010 the Company issued 750,000 shares of common stock per a forbearance agreement on a promissory note resulting in the recognition of interest expense of $7,500. |
|
In December 2010 the Company issued 5,555,556 shares of common stock for the settlement of previously accrued professional fees totaling $25,000 and the recognition of financing fees included in interest expense of $30,556. |
|
In December 2010 the Company issued 267,074 shares of common stock as interest on previously accrued and unpaid operating obligations resulting in the recognition of interest expense totaling $2,270. |
|
In January 2011 the Company issued 361,699 shares of common stock as interest on previously accrued and unpaid operating obligations resulting in the recognition of interest expense totaling $3,436. |
|
In January 2011 the Company issued 450,000 shares of common stock per the terms of three promissory notes resulting in the recognition of interest expense of $4,050. |
|
In January 2011 the Company issued 5,688 shares of common stock as interest on previously accrued and unpaid operating obligations resulting in the recognition of interest expense totaling $51. |
|
In January 2011 the Company issued 2,829,667 shares of common stock as interest on previously accrued and unpaid operating obligations resulting in the recognition of interest expense totaling $25,467. |
|
In January 2011 the Company issued 1,000,000 shares of common stock as compensation for consulting services totaling $9,000. |
|
In January 2011 the Company issued 7,692,307 shares of common stock for the settlement of previously accrued professional fees totaling $30,000 and the recognition of financing fees included in interest expense of $36,923. |
|
In February 2011 the Company issued 8,955,224 shares of common stock for the settlement of previously accrued professional fees totaling $30,000 and the recognition of financing fees included in interest expense of $28,209. |
|
In March 2011 the Company issued 20,000,000 shares of common stock for conversion from debt to equity of four promissory notes totaling $55,000, the Company also recognized financing fees associated with the conversion of $55,000 included in interest expense. |
|
In March 2011 the Company issued 450,000 shares of common stock per the terms of five promissory notes resulting in the recognition of interest expense of $2,475. |
|
In March 2011 the Company issued 5,000,000 shares of common stock for conversion from debt to equity in a promissory note in the amount of $25,000, the Company recognized a gain on the conversion in the amount of $14,000. |
|
In April 2011 the company issued 11,363,636 shares of common stock for the settlement of previously accrued professional fees totaling $55,000 and the recognition of a gain netted against financing fees included in interest expense of $15,227. |
|
In May 2011 the Company issued 26,183,333 shares of common stock for the settlement of promissory notes totaling $5,000 and the recognition of financing fees included in interest expense of $52,603. |
|
In October 2011 the Company issued 167,000,000 shares of common stock per the terms of six promissory notes totaling resulting in the recognition of interest expense of $751,500. |
|
In December 2011 the Company issued 12,591,332 shares of common stock for interest expense totaling $12,591. |
|
Stock Options |
|
In prior periods, the Company issued stock options to both non-employees and employees. The options are fully vested and all associated compensation expense was recognized in periods prior to those presented. The stock option grant date fair value was estimated using a Black-Scholes pricing model. No additional options were granted during the years ended December 31, 2012, 2011 and 2010. |
|
As of December 31, 2012 the Company had 25,000,000 stock options outstanding. During the periods presented there were no options granted, exercised, cancelled, or forfeited, correspondingly, no additional compensation expense was recognized for the periods presented. All options outstanding are exercisable and do not have any intrinsic value at December 31, 2012, 2011 and 2010 and are set to expire in October of 2017. At December 31, 2012 the weighted average exercise price of the outstanding options was $0.15 with a weighted average remaining term of 4.83 years. |
|
Warrants |
|
In periods prior to those presented, the Company issued warrants to non-employees primarily in conjunction with notes payable. As of the balance sheet dates contained in these financial statements, the Company had outstanding warrants of 38,350,000. The weighted average exercise price of the outstanding warrants at December 31, 2012, 2011and 2010 was $0.02 with a weighted average remaining term of 4.83 years as of December 31, 2012. The warrants did not have any intrinsic value as of December 31, 2013 and 2012 and were fully vested. Of the outstanding warrants, 37,950,000 are contingently exercisable only in the event that other equity-linked instruments are exercised. |
|